Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis
Funds UK research institutions to build up to three Innovation Hubs that translate new lung health and infection treatments for people with cystic fibrosis.
The overall commitment is £15 million spread over five years across the network. Each Hub proposal has to lay out its approach to industry engagement, business development, and how it will handle institutional communications, and hubs are strongly encouraged to show how they would leverage extra funding from other partners on top of what LifeArc and the Trust provide. Collaboration is treated as e…
The Hub Network is looking for interdisciplinary teams to tackle new and repurposed therapeutics for lung infection and inflammation, prevention and treatment of exacerbations, and diagnosis of infection and inflammation in cystic fibrosis. Each Hub does not need to cover every theme, but must show a clear route to improving lung health.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Write proposalGrant Writing Tips: Mistakes That Kill Deeptech Applications
Grant writing tips for deeptech founders, focused on mistakes reviewers penalize: weak fit, vague innovation, poor evidence, bad budgets, and rushed submissions.
More from LifeArc
All grants from this funder →LifeArc Early Ventures
🇬🇧LifeArc · United Kingdom
Funds early-stage life science ventures with seed and Series A equity across therapeutics and medical device innovation.
LifeArc Rare Disease Clinical Trials Programme
🇬🇧LifeArc · United Kingdom
Supports clinical rare-disease teams with practical trial design and execution.
Drug Repurposing Call to Treat Chronic Respiratory Infection
🇬🇧LifeArc · United Kingdom
Funds UK-led consortia repurposing drugs for bronchiectasis and cystic fibrosis.
LifeArc and Action Medical Research Fund
🇬🇧LifeArc · United Kingdom
Co-funds UK translational research turning rare-disease science into treatments.
LifeArc Gene Therapy Innovation Fund
🇬🇧LifeArc · United Kingdom
Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.
LifeArc KT Innovation Fellowship
🇬🇧LifeArc · United Kingdom
Supports career fellowship for early career European life scientists entering technology transfer travel expenses only no stipend.
Similar grants
Browse the directory →
Innovative healthcare interventions for non-communicable diseases
🇪🇺European Commission · European Union
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Advancing innovation in accelerated cancer diagnosis
🇬🇧Innovate UK · United Kingdom
Supporting clinical validation of early cancer diagnostic technologies
SMART Innovation Funding
🇬🇧Business Wales · United Kingdom
Funds Wales-based businesses of all sizes to research and develop new products, processes, or services through discretionary Welsh Government R&D grants.
SMART Innovation Funding
🇬🇧Welsh Gov · United Kingdom
Funds Welsh organizations developing new or significantly improved products, processes, and services.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.